Organization
Cloudbreak Therapeutics
5 clinical trials
Clinical trial
A Phase 2 Multicenter, Randomized, Vehicle-Controlled Study to Evaluate the Safety and Efficacy of CBT-004 Ophthalmic Emulsion in Patients With Vascularized PingueculaStatus: Recruiting, Estimated PCD: 2025-08-01
Clinical trial
Multicenter, Double-Masked, Randomized, Vehicle-Controlled 12-Month Parallel Comparison of the Safety and Efficacy of 0.1% and 0.2% CBT-001 Versus Vehicle, Dosed Twice-Daily, in Patients With PterygiumStatus: Recruiting, Estimated PCD: 2025-12-31
Clinical trial
A Two-Stage, Phase 1/2 Study to Evaluate the Safety, Tolerability and Pharmacodynamics of CBT-009 Eye Drop in Healthy VolunteersStatus: Completed, Estimated PCD: 2023-01-18
Clinical trial
A Phase 2 Multicenter, Double-masked, Randomized, Vehicle-controlled, Parallel Study to Evaluate the Safety, Efficacy and Pharmacokinetics of CBT-006 in Patients With Meibomian Gland DysfunctionStatus: Completed, Estimated PCD: 2023-08-17
Clinical trial
A Phase 2 Multicenter, Double-masked, Randomized, Vehicle-controlled, Parallel Study to Evaluate the Safety, Efficacy and Pharmacokinetics of CBT-008 in Patients With Meibomian Gland DysfunctionStatus: Completed, Estimated PCD: 2022-09-07